-

AHF Lauds News of 3 Million US COVID-19 Vaccines Daily by April

World’s largest AIDS group urges administration to also deploy Ryan White clinics as vaccination sites to better reach ambitious and lifesaving target

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomed news that the U.S. will have 3 million vaccine doses per day available by April. (See February 23, 2021 Politico article).

Executives from vaccine makers AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer testified yesterday at the U.S. House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations where each presented the scaled-up production numbers for the vaccines that have been approved by the U.S. Food and Drug Administration (FDA).

“The news that we’re finally scaling up vaccine production to levels that can bring this epidemic under control is very encouraging,” said John Hassell, national director of advocacy for AHF. “I’m confident in the rigorous approval process each of these vaccines have undergone at the FDA ensuring the vaccines are safe and effective. Ryan White HIV Clinics, like the 68 healthcare centers AHF operates in 16 states, the District of Columbia and Puerto Rico, stand ready to offer our sites to administer COVID-19 vaccines. We’re in a race against COVID variants. We’re eager to help reach the vulnerable populations that trust Ryan While clinics to provide competent and compassionate care.”

About AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.5 million people in 45 countries worldwide in the U.S., Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

Ged Kenslea, Senior Director, Communications, AHF
+1.323.791.5526 [cell]
+1.323.308.1833 [work]
gedk@aidshealth.org

John Hassell, National Director of Advocacy, AHF
+1.202.774.4854 [cell]
John.hassell@aidshealth.org

AIDS Healthcare Foundation


Release Summary
AHF Lauds News of 3 Million US COVID-19 Vaccines Daily by April
Release Versions

Contacts

Ged Kenslea, Senior Director, Communications, AHF
+1.323.791.5526 [cell]
+1.323.308.1833 [work]
gedk@aidshealth.org

John Hassell, National Director of Advocacy, AHF
+1.202.774.4854 [cell]
John.hassell@aidshealth.org

More News From AIDS Healthcare Foundation

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom